Skip to main content
Clinical Trials/ACTRN12607000202460
ACTRN12607000202460RecruitingPhase 4

A double blind randomised controlled cross-over trial of the effect of high flow oxygen on myocardial ischaemia during exercise treadmill testing (ETT)

Dr Mark Simmonds0 sites20 target enrollmentStarted: April 12, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Inducible ischaemia on ETT with chest pain.

Exclusion Criteria

  • Abnormal resting electrocardiogram (ECG)ST-elevation during the ETTGlobal ischaemia during the ETT suggesting a possible left main stem lesionArrythmia during the ETTUnstable angina (daily episodes at rest)Left bundle branch block developing during the ETTCongestive heart failureSevere hypertension (systolic >200mmHg)Chronic obstructive respiratory disease or other respiratory disease with oxygen saturations measured at <92% on room airPatients who do not develop chest pain despite evidence of inducible ischaemiaUnstable gaitPatients with contraindication to aspirin, metoprolol or simvastatin.

Investigators

Sponsor
Dr Mark Simmonds

Similar Trials